Collectively, these findings underscore the need for further mechanistic studies to explore the role of MMP-10 and MMP-7 in the pathophysiology of PAD, CAD, and CVD, with the long-term aim of identifying novel therapeutic targets to improve cardiovascular outcomes in patients with systemic atherosclerosis. The gene discussed is MMP10; the disease is peripheral arterial disease.